Interim analysis of a phase 1, open-label, dose-escalation study of SGN-CD19A in patients with relapsed or refractory B-lineage non-Hodgkin lymphoma (NHL) Meeting Abstract
| Authors: | Forero-Torres, A.; Moskowitz, C.; Advani, R. H.; Shah, B. D.; Kostic, A.; Albertson, T. M.; Sandalic, L.; Zhao, B. T.; Fanale, M. A. |
| Abstract Title: | Interim analysis of a phase 1, open-label, dose-escalation study of SGN-CD19A in patients with relapsed or refractory B-lineage non-Hodgkin lymphoma (NHL) |
| Meeting Title: | 50th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 32 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2014 May 30-Jun 3 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2014-05-20 |
| Language: | English |
| ACCESSION: | WOS:000358613204186 |
| PROVIDER: | wos |
| DOI: | 10.1200/jco.2014.32.15_suppl.8505 |
| Notes: | Meeting Abstract: 8505 -- Source: Wos |
